Modulation of insulin-dependent diabetes mellitus (IDDM) in NOD mice by autoreactive T cells

Critical Reviews in Immunology

Volumn 17, Issue 5-6, 1997, Pages 519-528

  Chaturvedi, Pratibha ^a   Qin, Hui Yu ^a   Chou, Henry ^a   Singh, Bhagirath ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

I A(g7); IDDM; NOD; Regulatory T cells

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNITY; CONFERENCE PAPER; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNE TOLERANCE; MICE; MICE, INBRED NOD; T-LYMPHOCYTES;

EID: 0030666685     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (74)

1. Castano, L. and Eisenbarth, G., Type I diabetes: a chronic autoimmune disease of human, mouse, and rat, Ann. Rev. Immunol., 8, 647, 1990.
2. + islet specific T cell clone, Science, 249, 1433, 1990.
3. Shizuru, J. A., Taylor-Edwards, C., Banks, B. A., Gregory, A. K., and Fathman, C. G., Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes, Science, 240, 659, 1988.
4. Wang, Y., Hao, L., Gill, R. G., and Lafferty, K. J., Autoimmune diabetes in NOD mouse is L3T4-lymphocyte dependent, Diabetes, 36, 535, 1987.
5. Katz, J. D., Banoist, C., and Mathis, D., T helper cell subsets in insulin-dependent diabetes, Science, 268, 1185, 1995.
6. Nagata, M. and Yoon, J. W., Studies on autoimmunity for T cell-mediated β cell destruction. Distinct difference in β cell destruction between CD4+ and CD8+ T cell clones derived from lymphocytes infiltrating the islets of NOD mice, Diabetes, 152, 2042, 1994.
7. Nagata, M., Santamaria, P., Kawamura, T., Utsugi, T., and Yoon, J. W., Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic β cells in NOD mice, J. Immunol., 152, 2042, 1994.
8. a donor, Diabetes, 42, 44, 1993.
9. Prochazka, M., Gaskins, H. R., Shultz, L. D., and Leiter, E. H., The NOD-scid mouse: a model for spontaneous thymomagenesis associated with immunodeficiency, Proc. Natl. Acad. Sci. U.S.A., 89, 3290, 1992.
10. Serreze, D. V., Leiter, E. H., Christianson, G. J., Greiner, D., and Roopenian, D. C., Major histocompatibility complex class I-deficient NOD-B2 m null mice are diabetes and insulitis resistant, Diabetes, 43, 505, 1994.
11. Wong, F. S., Visintin, I., Wen, L., Flavell, R. A., and Janeway, Jr., CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells, J. Exp. Med., 183, 67, 1996.
12. Reich, E.-P., Sherwin, R., Kanagawa, O., and Janeway, C., An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes, Nature, 341, 326, 1989.
13. Nishimoto, H., Kikutani, H., Yamamura, K., and Kishimoto, T., Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice, Nature, 328, 432, 1987.
14. Bohme, J., Schuhbaur, B., Kanagawa, O., Benoist, C., and Mathis, D., MHC-linked protection form diabetes dissociated from clonal deletion of T cells, Science, 249, 293, 1990.
15. Miyazaki, T., Uno, M., Uehira, M., Kikutani, H., Kishimoto, T., Kimoto, M., Nishimoto, H., Miyazai, J., and Yamamura, K.-I., Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice, Nature, 345, 722, 1990.
16. k transgenic mice, Nature, 345, 724, 1990.
17. Lund, T., O'Reily, L., Hutchings, P., Kawagawa, O., Simpson, E., Gravely, R., Chandler, P., Dyson, J., Picard, J. K., Edwards, A., Kioussis, D., and Cooke, A., Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain, Nature, 345, 727, 1990.
18. Morel, P. A., Dorman, J. S., Todd, J. A., McDevitt, H. O., and Trucco, M., Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study, Proc. Natl. Acad. Sci. U.S.A., 85, 8111, 1988.
19. Todd, J. A., Bell, J. I., and McDevitt, H. O., HLA-DQb gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus, Nature, 329, 599, 1987.
20. Kappler, J. W., Roehm, N., and Marrack, P., T cell tolerance by clonal elimination in the thymus, Cell, 49, 273, 1987.
21. Kappler, J. W., Staerz, U., White, J., and Marrack, P., Self tolerance eliminates T cells specific for Mlsmodified products of the major histocompatibility complex, Nature, 342, 183, 1989.
22. Gammon, G. and Sercarz, E. E., How some T cells escape tolerance induction, Nature, 342, 183, 1989.
23. Siegel, R. M., Katsumata, M., Komori, S., Wadsworth, S., Gill-Morse, L., Jerrold-Jones, S., Bhandoola, A., Greene, M. I., and Yui, K., Mechanisms of autoimmunity in the context of T-cell tolerance: insights from natural and transgenic animal model systems, Immunol. Rev., 118, 165, 1990.
24. Katz, A., Benoist, C., and Mathis, D., Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice, Eur. J. Immunol., 23, 3358, 1993.
25. Huang, R., Guo, J., Li, X., and Faustman, D. L., Elimination of self-peptide major histocompatibility complex class I reactivity in NOD and beta 2-microglobulin-negative mice, Diabetes, 44, 1114, 1995.
26. Agrawal, B., Manickasundari, M., Fraga, E., and Singh, B., T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice, J. Immunol., 147, 383, 1991.
27. Benichou, G., Takizawa, P. A. Ho, P. T., Killion, C. C., Olson, C. A., McMillan, M., and Sercarz, E. E., Immunogenecity and tolerogenecity of delf major histocompatibility complex peptides, J. Exp. Med., 172, 1341, 1990.
28. Ridgway, W. M., Fasso, M., Lanctot, A., Garvey, C., and Fathman, C. G., Breaking self-tolerance in nonobese diabetic mice, J. Exp. Med., 183, 1657, 1996.
29. Lee, J. M., Mckean, D. J., and Watts, T. H., Functional mapping of MHC class II polymorphic residues, J. Immunol., 146, 2952, 1991.
30. Brown, J. H., Jardetzky, T., Saper, M. A., Samraoui, B., Bjorkman, P. J., and Wiley, D. C., A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules, Nature, 332, 845, 1988.
31. Ramsdell, F. and Fowlkes, B. J., Maintainence of in vivo tolerance by persistence of antigen, Science, 257, 1130, 1992.
32. Ohtekei, T., Okuyama, R., Seiki, S., Abo, T., Sugiura, K., Kusumi, A., Ohmori, T., Watanabe, H., and Kumagai, K., Age dependent increase of extrathymic T cells in the liver and their appearance in the periphery of older mice, J. Immunol., 149, 1562, 1990.
33. Pankewycz, O., Strom, T. B., and Rubin-Kelley, V. E., Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes, Eur. J. Immunol., 21, 873, 1991.
34. Boitard, C., Yasunami, R., Dardenne, M., and Bach, J. F., T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice, J. Exp. Med., 169, 1669, 1989.
35. Hutchings, P. R. and Cooke, A., The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males, J. Autoimmunity, 3, 175, 1990.
36. Serreze, D. V. and Leiter, E. H., Defective activation of T suppressor cell function in nonobese diabetic mice - potential relation to cytokine deficiencies, J. Immunol., 140, 3801, 1988.
37. Chosich, N. and Harrison, L. C., Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line, Diabetologia, 36, 716, 1993.
38. Akhtar, I., Gold, J. P., Pan, L. Y., Ferrara, J. L. M., Yang, Z. D., Kim, J. I., and Tan, K. N., CD4+ b islet-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice, J. Exp. Med., 182, 87, 1995.
39. Han, H.-S., Utsugi, T., and Yoon, J. W., A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice, J. Autoimmunity, 9, 331, 1996.
40. Qin, H., Sadelain, M. W. L., Hitchon, C., Lauzon, J., and Singh, B., Complete Freund's adjuvant induced T cell prevent the development and adoptive transfer of diabetes in non-obese diabetic (NOD) mice, J. Immunol., 150, 2072, 1993.
41. Sadelain, M. W. J., Qin, H., Lauzon, J., and Singh, B., Prevention of type I diabetes in NOD mice by adjuvant immunotherapy, Diabetes, 39, 583, 1990.
42. Qin, H., Suarez, W. L., Parfrey, N., Power, R., and Rabinovitch, A., Mechanisms of complete Freund's adjuvant protection against diabetes in BB rats: induction of non-specific suppressor cells, Autoimmunity, 12, 193, 1992.
43. Diaz-Gallo, C., Mascovitch-Lopatin, M., Strom, T. B., and Rubin-Kelley, V., An anergic, islet-infiltrating T-cell clone that suppresses murine diabetes secretes a factor that blocks interleukin 2/interleukin 4-dependent proliferation, Proc. Natl. Acad. Sci. U.S.A., 89, 8656, 1992.
44. Epstein, S. P., Baer, R. L., Thorbecke, G. J., and Belsito, D. V., Immunosuppressive effects of transforming growth factor beta: inhibition of the induction of Ia antigen on Langerhans cells by cytokines and of the contact hypersensitivity response, J. Invest. Dermatol., 96, 832, 1991.
45. Czarniecki, C. W., Chiu, H. H., Wong, G. H. W., McCabe, S. M., and Palladino, M. A., Transforming growth factor-b1 modulates the expression of class II histocompatibility antigens on human cells, J. Immunol., 140, 4217, 1988.
46. Cai, J. P., Falanga, V., and Chin, Y. H., Transforming growth factor beta regulates the adhesive interactions between mononuclear cell and microvascular endothelium, J. Invest. Dermatol., 91, 169, 1991.
47. Fabry, Z., Topham, D. J., Fee, D., Herlein, J., Carline, J. A., Hart, M. N., and Sriram, S., TGF-β2 decreases migration of lymphocytes in vitro and homing of cells into the central nrevous system in vivo, J. Immunol., 155, 325, 1995.
48. Rook, A. H., Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Sporn, M. B., Burling, D. B., Lane, H. C., and Fauci, A. S., Effects of transforming growth factor b on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness, J. Immunol., 136, 3916, 1986.
49. Kasid, A., Bell, G. I., and Director, E. P., Effects of transforming growth factor b on human lymphokine activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells, J. Immunol., 141, 690, 1988.
50. Boutard, V., Harouis, R., Fouqueray, B., Philippe, C., Moulinoux, J., and Baud, L., Transforming growth factor-β stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity, J. Immunol., 155, 2077, 1995.
51. Satoh, J., Seino, H., Abo, T., Tanaka, S., Shintani, S., Ohta, S., Tamura, K., Sawai, T., Nobugana, T., Oteki, T., Kumagai, K., and Toyota, T., Recombinant human tumor necrosis factor a suppresses autoimmune diabetes in nonobese diabetic mice, J. Clin. Invest., 84, 1345, 1989.
52. Jacob, C. O., Aiso, S., Michie, S. A., McDevitt, H. O., and Acha-Orbea, H., Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and interleukin 1, Proc. Natl. Acad. Sci. U.S.A., 87, 968, 1990.
53. Yoshikawa, T. and Streilein, J. W., Genetic basis of the effects of ultraviolet light B on cutaneous immunity. Evidence that polymorphism at the TNF-α and Lps loci governs susceptibility, Immunogenetics, 32, 398, 1990.
54. Mason, D. and Fowell, D., T-cell subsets in autoimmunity, Curr. Opin. Immunol., 4, 728, 1992.
55. Scott, B., Liblau, R., Degermann, S., Marconi, L. A., Ogata, L., Caton, A. J., McDevitt, H. O., and Lo, D., A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity, Immunity, 1, 73, 1994.
56. Pennline, K. J., Roque-Gaffney, E., and Manahan, M., Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse, Clin. Immunol. Immunopathol., 71, 169, 1994.
57. Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A., and Murphy, K. M., Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages, Science, 260, 547, 1993.
58. Wogensen, L., Lee, M.-S., and Sarvetnick, N., Production of interleukin 10 by islet cells accelerates immune-mediated destruction of b cells in nonobese diabetic mice, J. Exp. Med., 179, 1379, 1994.
59. Anderson, J. T., Cornelius, A. J., Jarpe, A. J., Winter, W. E., and Peck, A. B., Insulin-dependent diabetes in NOD mouse model II. b cell destruction in autoimmune diabetes is a Th2 and not Th1 mediated event, J. Autoimmunity, 15, 113, 1993.
60. Baum, H., Davies, H., and Peakman, M., Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol. Today, 17, 64, 1996.
61. Boitard, C., Villa, M. C., Becourt, H., Gia, P., Huc, C., Sempe, P., Portier, M. M., and Bach, J. F., Peripherin: an islet antigen that is cross reactive with nonobese diabetic mouse class II gene products, Proc. Natl. Acad. Sci. U.S.A., 89, 172, 1992.
62. Honeyman, M. C., Cram, D. S., and Harrison, L. C., Transcription factor jun-B is target of autoreactive T-cells in IDDM, Diabetes, 42, 626, 1993.
63. Rabin, D. U., Pleasic, M., and Shapiro, J. A., Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatase, J. Immunol., 152, 3183, 1994.
64. Reich, E.-P., Scaringe, D., Yagi, J., Sherwin, R. S., and Janeway, C. A., Jr., Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes, Diabetes, 38, 1647, 1989.
65. Serreze, D. V., Hamaguchi, K., and Leiter, E. H., Immunostimulation circumvents diabetes in NOD/Lt mice, J. Autoimmunity, 2, 759, 1989.
66. Chervonsky, A. V., Wang, Y., Wong, F. S., Visintin, I., Flavell, R. A., Janeway, C. A., Jr., and Matis, L. A., The role of Fas in autoimmune diabetes, Cell, 89, 17, 1997.
67. Rapoport, M. J., Zipris, D., Lazarus, D., Jaramillo, A., Serreze, D. V., Leiter, E. H., Cyopick, P., Danska, J., and Delovitch, T. L., IL-4 reverses thymic T cell proliferative unresponsiveness and prevents diabetes in NOD mice, J. Exp. Med., 178, 87, 1993.
68. Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M. K., and Adorini, L., Interleukin-12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice, J. Exp. Med., 181, 817, 1995.
69. Yang, X.-D., Tisch, R., Singer, S. M., Cao, Z. A., Liblau, R. S., Schreiber, R. D., and McDevitt, H. O., Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process, J. Exp. Med., 180, 995, 1994.
70. Stewart, T. A., Hultgren, B., Huang, X., Pitts-Meek, S., Hully, J., and MacLachlan, N. J., Induction of type I diabetes by interferon-α in transgenic mice, Science, 260, 1942, 1993.
71. Debray-Sachs, M., Carnaud, C., Boitard, C., Cohen, H., Gresser, I., Bedossa, P., and Bach, J. F., Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma, J. Autoimmunity, 4, 237, 1991.
72. Allisson, J., McClive, P., Oxbrow, L., Baxter, A., Morahan, G., and Miller, J. F. A. P., Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet β-cells, Eur. J. Immunol., 24, 2535, 1994.
73. Mueller, R., Krahl, T., and Sarvetnick, N., Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in non-obese diabetic (NOD) mice, J. Exp. Med., 184, 1093, 1996.
74. Sarvetnick, N., Shizuru, J., Liggit, D., Martin, L., McIntyre, B., Gregory, A., Parslow, T., and Stewart, T., Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ, Nature, 346, 844, 1990.